Global Chronic Obstructive Pulmonary Disease Market Research Report 2024(Status and Outlook)
Report Overview:
Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult .Chronic bronchitis and emphysema are older terms used for different types of COPD.
The Global Chronic Obstructive Pulmonary Disease Market Size was estimated at USD 4113.67 million in 2023 and is projected to reach USD 4826.71 million by 2029, exhibiting a CAGR of 2.70% during the forecast period.
This report provides a deep insight into the global Chronic Obstructive Pulmonary Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chronic Obstructive Pulmonary Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chronic Obstructive Pulmonary Disease market in any manner.
Global Chronic Obstructive Pulmonary Disease Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca
GSK
MSD
Sunovion
Novartis
Roche Group
Pfizer
Jubilant Pharma Limited
Almirall
Horizon Pharma
Boehringer Ingelheim
Market Segmentation (by Type)
Bronchodilators
Glucocorticoids
Other
Market Segmentation (by Application)
Prevention
Diagnostic
Treatment
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chronic Obstructive Pulmonary Disease Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult .Chronic bronchitis and emphysema are older terms used for different types of COPD.
The Global Chronic Obstructive Pulmonary Disease Market Size was estimated at USD 4113.67 million in 2023 and is projected to reach USD 4826.71 million by 2029, exhibiting a CAGR of 2.70% during the forecast period.
This report provides a deep insight into the global Chronic Obstructive Pulmonary Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chronic Obstructive Pulmonary Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chronic Obstructive Pulmonary Disease market in any manner.
Global Chronic Obstructive Pulmonary Disease Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca
GSK
MSD
Sunovion
Novartis
Roche Group
Pfizer
Jubilant Pharma Limited
Almirall
Horizon Pharma
Boehringer Ingelheim
Market Segmentation (by Type)
Bronchodilators
Glucocorticoids
Other
Market Segmentation (by Application)
Prevention
Diagnostic
Treatment
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Chronic Obstructive Pulmonary Disease Market
- Overview of the regional outlook of the Chronic Obstructive Pulmonary Disease Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chronic Obstructive Pulmonary Disease Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Chronic Obstructive Pulmonary Disease
1.2 Key Market Segments
1.2.1 Chronic Obstructive Pulmonary Disease Segment by Type
1.2.2 Chronic Obstructive Pulmonary Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Chronic Obstructive Pulmonary Disease Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Chronic Obstructive Pulmonary Disease Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET COMPETITIVE LANDSCAPE
3.1 Global Chronic Obstructive Pulmonary Disease Sales by Manufacturers (2019-2024)
3.2 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Manufacturers (2019-2024)
3.3 Chronic Obstructive Pulmonary Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Chronic Obstructive Pulmonary Disease Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Chronic Obstructive Pulmonary Disease Sales Sites, Area Served, Product Type
3.6 Chronic Obstructive Pulmonary Disease Market Competitive Situation and Trends
3.6.1 Chronic Obstructive Pulmonary Disease Market Concentration Rate
3.6.2 Global 5 and 10 Largest Chronic Obstructive Pulmonary Disease Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CHRONIC OBSTRUCTIVE PULMONARY DISEASE INDUSTRY CHAIN ANALYSIS
4.1 Chronic Obstructive Pulmonary Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chronic Obstructive Pulmonary Disease Sales Market Share by Type (2019-2024)
6.3 Global Chronic Obstructive Pulmonary Disease Market Size Market Share by Type (2019-2024)
6.4 Global Chronic Obstructive Pulmonary Disease Price by Type (2019-2024)
7 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chronic Obstructive Pulmonary Disease Market Sales by Application (2019-2024)
7.3 Global Chronic Obstructive Pulmonary Disease Market Size (M USD) by Application (2019-2024)
7.4 Global Chronic Obstructive Pulmonary Disease Sales Growth Rate by Application (2019-2024)
8 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SEGMENTATION BY REGION
8.1 Global Chronic Obstructive Pulmonary Disease Sales by Region
8.1.1 Global Chronic Obstructive Pulmonary Disease Sales by Region
8.1.2 Global Chronic Obstructive Pulmonary Disease Sales Market Share by Region
8.2 North America
8.2.1 North America Chronic Obstructive Pulmonary Disease Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Chronic Obstructive Pulmonary Disease Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Chronic Obstructive Pulmonary Disease Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Chronic Obstructive Pulmonary Disease Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AstraZeneca
9.1.1 AstraZeneca Chronic Obstructive Pulmonary Disease Basic Information
9.1.2 AstraZeneca Chronic Obstructive Pulmonary Disease Product Overview
9.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Product Market Performance
9.1.4 AstraZeneca Business Overview
9.1.5 AstraZeneca Chronic Obstructive Pulmonary Disease SWOT Analysis
9.1.6 AstraZeneca Recent Developments
9.2 GSK
9.2.1 GSK Chronic Obstructive Pulmonary Disease Basic Information
9.2.2 GSK Chronic Obstructive Pulmonary Disease Product Overview
9.2.3 GSK Chronic Obstructive Pulmonary Disease Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Chronic Obstructive Pulmonary Disease SWOT Analysis
9.2.6 GSK Recent Developments
9.3 MSD
9.3.1 MSD Chronic Obstructive Pulmonary Disease Basic Information
9.3.2 MSD Chronic Obstructive Pulmonary Disease Product Overview
9.3.3 MSD Chronic Obstructive Pulmonary Disease Product Market Performance
9.3.4 MSD Chronic Obstructive Pulmonary Disease SWOT Analysis
9.3.5 MSD Business Overview
9.3.6 MSD Recent Developments
9.4 Sunovion
9.4.1 Sunovion Chronic Obstructive Pulmonary Disease Basic Information
9.4.2 Sunovion Chronic Obstructive Pulmonary Disease Product Overview
9.4.3 Sunovion Chronic Obstructive Pulmonary Disease Product Market Performance
9.4.4 Sunovion Business Overview
9.4.5 Sunovion Recent Developments
9.5 Novartis
9.5.1 Novartis Chronic Obstructive Pulmonary Disease Basic Information
9.5.2 Novartis Chronic Obstructive Pulmonary Disease Product Overview
9.5.3 Novartis Chronic Obstructive Pulmonary Disease Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Roche Group
9.6.1 Roche Group Chronic Obstructive Pulmonary Disease Basic Information
9.6.2 Roche Group Chronic Obstructive Pulmonary Disease Product Overview
9.6.3 Roche Group Chronic Obstructive Pulmonary Disease Product Market Performance
9.6.4 Roche Group Business Overview
9.6.5 Roche Group Recent Developments
9.7 Pfizer
9.7.1 Pfizer Chronic Obstructive Pulmonary Disease Basic Information
9.7.2 Pfizer Chronic Obstructive Pulmonary Disease Product Overview
9.7.3 Pfizer Chronic Obstructive Pulmonary Disease Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Jubilant Pharma Limited
9.8.1 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Basic Information
9.8.2 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Product Overview
9.8.3 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Product Market Performance
9.8.4 Jubilant Pharma Limited Business Overview
9.8.5 Jubilant Pharma Limited Recent Developments
9.9 Almirall
9.9.1 Almirall Chronic Obstructive Pulmonary Disease Basic Information
9.9.2 Almirall Chronic Obstructive Pulmonary Disease Product Overview
9.9.3 Almirall Chronic Obstructive Pulmonary Disease Product Market Performance
9.9.4 Almirall Business Overview
9.9.5 Almirall Recent Developments
9.10 Horizon Pharma
9.10.1 Horizon Pharma Chronic Obstructive Pulmonary Disease Basic Information
9.10.2 Horizon Pharma Chronic Obstructive Pulmonary Disease Product Overview
9.10.3 Horizon Pharma Chronic Obstructive Pulmonary Disease Product Market Performance
9.10.4 Horizon Pharma Business Overview
9.10.5 Horizon Pharma Recent Developments
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Basic Information
9.11.2 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product Overview
9.11.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product Market Performance
9.11.4 Boehringer Ingelheim Business Overview
9.11.5 Boehringer Ingelheim Recent Developments
10 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET FORECAST BY REGION
10.1 Global Chronic Obstructive Pulmonary Disease Market Size Forecast
10.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Chronic Obstructive Pulmonary Disease Market Size Forecast by Country
10.2.3 Asia Pacific Chronic Obstructive Pulmonary Disease Market Size Forecast by Region
10.2.4 South America Chronic Obstructive Pulmonary Disease Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Chronic Obstructive Pulmonary Disease by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Chronic Obstructive Pulmonary Disease Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Chronic Obstructive Pulmonary Disease by Type (2025-2030)
11.1.2 Global Chronic Obstructive Pulmonary Disease Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Chronic Obstructive Pulmonary Disease by Type (2025-2030)
11.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Application (2025-2030)
11.2.1 Global Chronic Obstructive Pulmonary Disease Sales (K Units) Forecast by Application
11.2.2 Global Chronic Obstructive Pulmonary Disease Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Chronic Obstructive Pulmonary Disease
1.2 Key Market Segments
1.2.1 Chronic Obstructive Pulmonary Disease Segment by Type
1.2.2 Chronic Obstructive Pulmonary Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Chronic Obstructive Pulmonary Disease Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Chronic Obstructive Pulmonary Disease Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET COMPETITIVE LANDSCAPE
3.1 Global Chronic Obstructive Pulmonary Disease Sales by Manufacturers (2019-2024)
3.2 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Manufacturers (2019-2024)
3.3 Chronic Obstructive Pulmonary Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Chronic Obstructive Pulmonary Disease Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Chronic Obstructive Pulmonary Disease Sales Sites, Area Served, Product Type
3.6 Chronic Obstructive Pulmonary Disease Market Competitive Situation and Trends
3.6.1 Chronic Obstructive Pulmonary Disease Market Concentration Rate
3.6.2 Global 5 and 10 Largest Chronic Obstructive Pulmonary Disease Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CHRONIC OBSTRUCTIVE PULMONARY DISEASE INDUSTRY CHAIN ANALYSIS
4.1 Chronic Obstructive Pulmonary Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chronic Obstructive Pulmonary Disease Sales Market Share by Type (2019-2024)
6.3 Global Chronic Obstructive Pulmonary Disease Market Size Market Share by Type (2019-2024)
6.4 Global Chronic Obstructive Pulmonary Disease Price by Type (2019-2024)
7 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chronic Obstructive Pulmonary Disease Market Sales by Application (2019-2024)
7.3 Global Chronic Obstructive Pulmonary Disease Market Size (M USD) by Application (2019-2024)
7.4 Global Chronic Obstructive Pulmonary Disease Sales Growth Rate by Application (2019-2024)
8 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SEGMENTATION BY REGION
8.1 Global Chronic Obstructive Pulmonary Disease Sales by Region
8.1.1 Global Chronic Obstructive Pulmonary Disease Sales by Region
8.1.2 Global Chronic Obstructive Pulmonary Disease Sales Market Share by Region
8.2 North America
8.2.1 North America Chronic Obstructive Pulmonary Disease Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Chronic Obstructive Pulmonary Disease Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Chronic Obstructive Pulmonary Disease Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Chronic Obstructive Pulmonary Disease Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AstraZeneca
9.1.1 AstraZeneca Chronic Obstructive Pulmonary Disease Basic Information
9.1.2 AstraZeneca Chronic Obstructive Pulmonary Disease Product Overview
9.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Product Market Performance
9.1.4 AstraZeneca Business Overview
9.1.5 AstraZeneca Chronic Obstructive Pulmonary Disease SWOT Analysis
9.1.6 AstraZeneca Recent Developments
9.2 GSK
9.2.1 GSK Chronic Obstructive Pulmonary Disease Basic Information
9.2.2 GSK Chronic Obstructive Pulmonary Disease Product Overview
9.2.3 GSK Chronic Obstructive Pulmonary Disease Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Chronic Obstructive Pulmonary Disease SWOT Analysis
9.2.6 GSK Recent Developments
9.3 MSD
9.3.1 MSD Chronic Obstructive Pulmonary Disease Basic Information
9.3.2 MSD Chronic Obstructive Pulmonary Disease Product Overview
9.3.3 MSD Chronic Obstructive Pulmonary Disease Product Market Performance
9.3.4 MSD Chronic Obstructive Pulmonary Disease SWOT Analysis
9.3.5 MSD Business Overview
9.3.6 MSD Recent Developments
9.4 Sunovion
9.4.1 Sunovion Chronic Obstructive Pulmonary Disease Basic Information
9.4.2 Sunovion Chronic Obstructive Pulmonary Disease Product Overview
9.4.3 Sunovion Chronic Obstructive Pulmonary Disease Product Market Performance
9.4.4 Sunovion Business Overview
9.4.5 Sunovion Recent Developments
9.5 Novartis
9.5.1 Novartis Chronic Obstructive Pulmonary Disease Basic Information
9.5.2 Novartis Chronic Obstructive Pulmonary Disease Product Overview
9.5.3 Novartis Chronic Obstructive Pulmonary Disease Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Roche Group
9.6.1 Roche Group Chronic Obstructive Pulmonary Disease Basic Information
9.6.2 Roche Group Chronic Obstructive Pulmonary Disease Product Overview
9.6.3 Roche Group Chronic Obstructive Pulmonary Disease Product Market Performance
9.6.4 Roche Group Business Overview
9.6.5 Roche Group Recent Developments
9.7 Pfizer
9.7.1 Pfizer Chronic Obstructive Pulmonary Disease Basic Information
9.7.2 Pfizer Chronic Obstructive Pulmonary Disease Product Overview
9.7.3 Pfizer Chronic Obstructive Pulmonary Disease Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Jubilant Pharma Limited
9.8.1 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Basic Information
9.8.2 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Product Overview
9.8.3 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Product Market Performance
9.8.4 Jubilant Pharma Limited Business Overview
9.8.5 Jubilant Pharma Limited Recent Developments
9.9 Almirall
9.9.1 Almirall Chronic Obstructive Pulmonary Disease Basic Information
9.9.2 Almirall Chronic Obstructive Pulmonary Disease Product Overview
9.9.3 Almirall Chronic Obstructive Pulmonary Disease Product Market Performance
9.9.4 Almirall Business Overview
9.9.5 Almirall Recent Developments
9.10 Horizon Pharma
9.10.1 Horizon Pharma Chronic Obstructive Pulmonary Disease Basic Information
9.10.2 Horizon Pharma Chronic Obstructive Pulmonary Disease Product Overview
9.10.3 Horizon Pharma Chronic Obstructive Pulmonary Disease Product Market Performance
9.10.4 Horizon Pharma Business Overview
9.10.5 Horizon Pharma Recent Developments
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Basic Information
9.11.2 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product Overview
9.11.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product Market Performance
9.11.4 Boehringer Ingelheim Business Overview
9.11.5 Boehringer Ingelheim Recent Developments
10 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET FORECAST BY REGION
10.1 Global Chronic Obstructive Pulmonary Disease Market Size Forecast
10.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Chronic Obstructive Pulmonary Disease Market Size Forecast by Country
10.2.3 Asia Pacific Chronic Obstructive Pulmonary Disease Market Size Forecast by Region
10.2.4 South America Chronic Obstructive Pulmonary Disease Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Chronic Obstructive Pulmonary Disease by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Chronic Obstructive Pulmonary Disease Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Chronic Obstructive Pulmonary Disease by Type (2025-2030)
11.1.2 Global Chronic Obstructive Pulmonary Disease Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Chronic Obstructive Pulmonary Disease by Type (2025-2030)
11.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Application (2025-2030)
11.2.1 Global Chronic Obstructive Pulmonary Disease Sales (K Units) Forecast by Application
11.2.2 Global Chronic Obstructive Pulmonary Disease Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Chronic Obstructive Pulmonary Disease Market Size Comparison by Region (M USD)
Table 5. Global Chronic Obstructive Pulmonary Disease Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Chronic Obstructive Pulmonary Disease Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Chronic Obstructive Pulmonary Disease Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease as of 2022)
Table 10. Global Market Chronic Obstructive Pulmonary Disease Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Chronic Obstructive Pulmonary Disease Sales Sites and Area Served
Table 12. Manufacturers Chronic Obstructive Pulmonary Disease Product Type
Table 13. Global Chronic Obstructive Pulmonary Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Chronic Obstructive Pulmonary Disease
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Chronic Obstructive Pulmonary Disease Market Challenges
Table 22. Global Chronic Obstructive Pulmonary Disease Sales by Type (K Units)
Table 23. Global Chronic Obstructive Pulmonary Disease Market Size by Type (M USD)
Table 24. Global Chronic Obstructive Pulmonary Disease Sales (K Units) by Type (2019-2024)
Table 25. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Type (2019-2024)
Table 26. Global Chronic Obstructive Pulmonary Disease Market Size (M USD) by Type (2019-2024)
Table 27. Global Chronic Obstructive Pulmonary Disease Market Size Share by Type (2019-2024)
Table 28. Global Chronic Obstructive Pulmonary Disease Price (USD/Unit) by Type (2019-2024)
Table 29. Global Chronic Obstructive Pulmonary Disease Sales (K Units) by Application
Table 30. Global Chronic Obstructive Pulmonary Disease Market Size by Application
Table 31. Global Chronic Obstructive Pulmonary Disease Sales by Application (2019-2024) & (K Units)
Table 32. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Application (2019-2024)
Table 33. Global Chronic Obstructive Pulmonary Disease Sales by Application (2019-2024) & (M USD)
Table 34. Global Chronic Obstructive Pulmonary Disease Market Share by Application (2019-2024)
Table 35. Global Chronic Obstructive Pulmonary Disease Sales Growth Rate by Application (2019-2024)
Table 36. Global Chronic Obstructive Pulmonary Disease Sales by Region (2019-2024) & (K Units)
Table 37. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Region (2019-2024)
Table 38. North America Chronic Obstructive Pulmonary Disease Sales by Country (2019-2024) & (K Units)
Table 39. Europe Chronic Obstructive Pulmonary Disease Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Chronic Obstructive Pulmonary Disease Sales by Region (2019-2024) & (K Units)
Table 41. South America Chronic Obstructive Pulmonary Disease Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Chronic Obstructive Pulmonary Disease Sales by Region (2019-2024) & (K Units)
Table 43. AstraZeneca Chronic Obstructive Pulmonary Disease Basic Information
Table 44. AstraZeneca Chronic Obstructive Pulmonary Disease Product Overview
Table 45. AstraZeneca Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AstraZeneca Business Overview
Table 47. AstraZeneca Chronic Obstructive Pulmonary Disease SWOT Analysis
Table 48. AstraZeneca Recent Developments
Table 49. GSK Chronic Obstructive Pulmonary Disease Basic Information
Table 50. GSK Chronic Obstructive Pulmonary Disease Product Overview
Table 51. GSK Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Chronic Obstructive Pulmonary Disease SWOT Analysis
Table 54. GSK Recent Developments
Table 55. MSD Chronic Obstructive Pulmonary Disease Basic Information
Table 56. MSD Chronic Obstructive Pulmonary Disease Product Overview
Table 57. MSD Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. MSD Chronic Obstructive Pulmonary Disease SWOT Analysis
Table 59. MSD Business Overview
Table 60. MSD Recent Developments
Table 61. Sunovion Chronic Obstructive Pulmonary Disease Basic Information
Table 62. Sunovion Chronic Obstructive Pulmonary Disease Product Overview
Table 63. Sunovion Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Sunovion Business Overview
Table 65. Sunovion Recent Developments
Table 66. Novartis Chronic Obstructive Pulmonary Disease Basic Information
Table 67. Novartis Chronic Obstructive Pulmonary Disease Product Overview
Table 68. Novartis Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. Roche Group Chronic Obstructive Pulmonary Disease Basic Information
Table 72. Roche Group Chronic Obstructive Pulmonary Disease Product Overview
Table 73. Roche Group Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Roche Group Business Overview
Table 75. Roche Group Recent Developments
Table 76. Pfizer Chronic Obstructive Pulmonary Disease Basic Information
Table 77. Pfizer Chronic Obstructive Pulmonary Disease Product Overview
Table 78. Pfizer Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Basic Information
Table 82. Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Product Overview
Table 83. Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Jubilant Pharma Limited Business Overview
Table 85. Jubilant Pharma Limited Recent Developments
Table 86. Almirall Chronic Obstructive Pulmonary Disease Basic Information
Table 87. Almirall Chronic Obstructive Pulmonary Disease Product Overview
Table 88. Almirall Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Almirall Business Overview
Table 90. Almirall Recent Developments
Table 91. Horizon Pharma Chronic Obstructive Pulmonary Disease Basic Information
Table 92. Horizon Pharma Chronic Obstructive Pulmonary Disease Product Overview
Table 93. Horizon Pharma Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Horizon Pharma Business Overview
Table 95. Horizon Pharma Recent Developments
Table 96. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Basic Information
Table 97. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product Overview
Table 98. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Boehringer Ingelheim Business Overview
Table 100. Boehringer Ingelheim Recent Developments
Table 101. Global Chronic Obstructive Pulmonary Disease Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Chronic Obstructive Pulmonary Disease Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Chronic Obstructive Pulmonary Disease Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Chronic Obstructive Pulmonary Disease Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Chronic Obstructive Pulmonary Disease Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Chronic Obstructive Pulmonary Disease Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Chronic Obstructive Pulmonary Disease Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Chronic Obstructive Pulmonary Disease Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Chronic Obstructive Pulmonary Disease Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Chronic Obstructive Pulmonary Disease Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Chronic Obstructive Pulmonary Disease Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Chronic Obstructive Pulmonary Disease Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Chronic Obstructive Pulmonary Disease Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Chronic Obstructive Pulmonary Disease Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Chronic Obstructive Pulmonary Disease Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Chronic Obstructive Pulmonary Disease Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Chronic Obstructive Pulmonary Disease Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Chronic Obstructive Pulmonary Disease Market Size Comparison by Region (M USD)
Table 5. Global Chronic Obstructive Pulmonary Disease Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Chronic Obstructive Pulmonary Disease Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Chronic Obstructive Pulmonary Disease Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease as of 2022)
Table 10. Global Market Chronic Obstructive Pulmonary Disease Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Chronic Obstructive Pulmonary Disease Sales Sites and Area Served
Table 12. Manufacturers Chronic Obstructive Pulmonary Disease Product Type
Table 13. Global Chronic Obstructive Pulmonary Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Chronic Obstructive Pulmonary Disease
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Chronic Obstructive Pulmonary Disease Market Challenges
Table 22. Global Chronic Obstructive Pulmonary Disease Sales by Type (K Units)
Table 23. Global Chronic Obstructive Pulmonary Disease Market Size by Type (M USD)
Table 24. Global Chronic Obstructive Pulmonary Disease Sales (K Units) by Type (2019-2024)
Table 25. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Type (2019-2024)
Table 26. Global Chronic Obstructive Pulmonary Disease Market Size (M USD) by Type (2019-2024)
Table 27. Global Chronic Obstructive Pulmonary Disease Market Size Share by Type (2019-2024)
Table 28. Global Chronic Obstructive Pulmonary Disease Price (USD/Unit) by Type (2019-2024)
Table 29. Global Chronic Obstructive Pulmonary Disease Sales (K Units) by Application
Table 30. Global Chronic Obstructive Pulmonary Disease Market Size by Application
Table 31. Global Chronic Obstructive Pulmonary Disease Sales by Application (2019-2024) & (K Units)
Table 32. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Application (2019-2024)
Table 33. Global Chronic Obstructive Pulmonary Disease Sales by Application (2019-2024) & (M USD)
Table 34. Global Chronic Obstructive Pulmonary Disease Market Share by Application (2019-2024)
Table 35. Global Chronic Obstructive Pulmonary Disease Sales Growth Rate by Application (2019-2024)
Table 36. Global Chronic Obstructive Pulmonary Disease Sales by Region (2019-2024) & (K Units)
Table 37. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Region (2019-2024)
Table 38. North America Chronic Obstructive Pulmonary Disease Sales by Country (2019-2024) & (K Units)
Table 39. Europe Chronic Obstructive Pulmonary Disease Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Chronic Obstructive Pulmonary Disease Sales by Region (2019-2024) & (K Units)
Table 41. South America Chronic Obstructive Pulmonary Disease Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Chronic Obstructive Pulmonary Disease Sales by Region (2019-2024) & (K Units)
Table 43. AstraZeneca Chronic Obstructive Pulmonary Disease Basic Information
Table 44. AstraZeneca Chronic Obstructive Pulmonary Disease Product Overview
Table 45. AstraZeneca Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AstraZeneca Business Overview
Table 47. AstraZeneca Chronic Obstructive Pulmonary Disease SWOT Analysis
Table 48. AstraZeneca Recent Developments
Table 49. GSK Chronic Obstructive Pulmonary Disease Basic Information
Table 50. GSK Chronic Obstructive Pulmonary Disease Product Overview
Table 51. GSK Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Chronic Obstructive Pulmonary Disease SWOT Analysis
Table 54. GSK Recent Developments
Table 55. MSD Chronic Obstructive Pulmonary Disease Basic Information
Table 56. MSD Chronic Obstructive Pulmonary Disease Product Overview
Table 57. MSD Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. MSD Chronic Obstructive Pulmonary Disease SWOT Analysis
Table 59. MSD Business Overview
Table 60. MSD Recent Developments
Table 61. Sunovion Chronic Obstructive Pulmonary Disease Basic Information
Table 62. Sunovion Chronic Obstructive Pulmonary Disease Product Overview
Table 63. Sunovion Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Sunovion Business Overview
Table 65. Sunovion Recent Developments
Table 66. Novartis Chronic Obstructive Pulmonary Disease Basic Information
Table 67. Novartis Chronic Obstructive Pulmonary Disease Product Overview
Table 68. Novartis Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. Roche Group Chronic Obstructive Pulmonary Disease Basic Information
Table 72. Roche Group Chronic Obstructive Pulmonary Disease Product Overview
Table 73. Roche Group Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Roche Group Business Overview
Table 75. Roche Group Recent Developments
Table 76. Pfizer Chronic Obstructive Pulmonary Disease Basic Information
Table 77. Pfizer Chronic Obstructive Pulmonary Disease Product Overview
Table 78. Pfizer Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Basic Information
Table 82. Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Product Overview
Table 83. Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Jubilant Pharma Limited Business Overview
Table 85. Jubilant Pharma Limited Recent Developments
Table 86. Almirall Chronic Obstructive Pulmonary Disease Basic Information
Table 87. Almirall Chronic Obstructive Pulmonary Disease Product Overview
Table 88. Almirall Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Almirall Business Overview
Table 90. Almirall Recent Developments
Table 91. Horizon Pharma Chronic Obstructive Pulmonary Disease Basic Information
Table 92. Horizon Pharma Chronic Obstructive Pulmonary Disease Product Overview
Table 93. Horizon Pharma Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Horizon Pharma Business Overview
Table 95. Horizon Pharma Recent Developments
Table 96. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Basic Information
Table 97. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product Overview
Table 98. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Boehringer Ingelheim Business Overview
Table 100. Boehringer Ingelheim Recent Developments
Table 101. Global Chronic Obstructive Pulmonary Disease Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Chronic Obstructive Pulmonary Disease Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Chronic Obstructive Pulmonary Disease Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Chronic Obstructive Pulmonary Disease Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Chronic Obstructive Pulmonary Disease Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Chronic Obstructive Pulmonary Disease Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Chronic Obstructive Pulmonary Disease Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Chronic Obstructive Pulmonary Disease Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Chronic Obstructive Pulmonary Disease Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Chronic Obstructive Pulmonary Disease Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Chronic Obstructive Pulmonary Disease Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Chronic Obstructive Pulmonary Disease Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Chronic Obstructive Pulmonary Disease Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Chronic Obstructive Pulmonary Disease Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Chronic Obstructive Pulmonary Disease Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Chronic Obstructive Pulmonary Disease Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Chronic Obstructive Pulmonary Disease Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Chronic Obstructive Pulmonary Disease
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Chronic Obstructive Pulmonary Disease Market Size (M USD), 2019-2030
Figure 5. Global Chronic Obstructive Pulmonary Disease Market Size (M USD) (2019-2030)
Figure 6. Global Chronic Obstructive Pulmonary Disease Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Chronic Obstructive Pulmonary Disease Market Size by Country (M USD)
Figure 11. Chronic Obstructive Pulmonary Disease Sales Share by Manufacturers in 2023
Figure 12. Global Chronic Obstructive Pulmonary Disease Revenue Share by Manufacturers in 2023
Figure 13. Chronic Obstructive Pulmonary Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Chronic Obstructive Pulmonary Disease Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Chronic Obstructive Pulmonary Disease Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Chronic Obstructive Pulmonary Disease Market Share by Type
Figure 18. Sales Market Share of Chronic Obstructive Pulmonary Disease by Type (2019-2024)
Figure 19. Sales Market Share of Chronic Obstructive Pulmonary Disease by Type in 2023
Figure 20. Market Size Share of Chronic Obstructive Pulmonary Disease by Type (2019-2024)
Figure 21. Market Size Market Share of Chronic Obstructive Pulmonary Disease by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Chronic Obstructive Pulmonary Disease Market Share by Application
Figure 24. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Application (2019-2024)
Figure 25. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Application in 2023
Figure 26. Global Chronic Obstructive Pulmonary Disease Market Share by Application (2019-2024)
Figure 27. Global Chronic Obstructive Pulmonary Disease Market Share by Application in 2023
Figure 28. Global Chronic Obstructive Pulmonary Disease Sales Growth Rate by Application (2019-2024)
Figure 29. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Region (2019-2024)
Figure 30. North America Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Chronic Obstructive Pulmonary Disease Sales Market Share by Country in 2023
Figure 32. U.S. Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Chronic Obstructive Pulmonary Disease Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Chronic Obstructive Pulmonary Disease Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Chronic Obstructive Pulmonary Disease Sales Market Share by Country in 2023
Figure 37. Germany Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Chronic Obstructive Pulmonary Disease Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Chronic Obstructive Pulmonary Disease Sales Market Share by Region in 2023
Figure 44. China Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Chronic Obstructive Pulmonary Disease Sales and Growth Rate (K Units)
Figure 50. South America Chronic Obstructive Pulmonary Disease Sales Market Share by Country in 2023
Figure 51. Brazil Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Chronic Obstructive Pulmonary Disease Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Chronic Obstructive Pulmonary Disease Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Chronic Obstructive Pulmonary Disease Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Chronic Obstructive Pulmonary Disease Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Chronic Obstructive Pulmonary Disease Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Chronic Obstructive Pulmonary Disease Market Share Forecast by Type (2025-2030)
Figure 65. Global Chronic Obstructive Pulmonary Disease Sales Forecast by Application (2025-2030)
Figure 66. Global Chronic Obstructive Pulmonary Disease Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Chronic Obstructive Pulmonary Disease
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Chronic Obstructive Pulmonary Disease Market Size (M USD), 2019-2030
Figure 5. Global Chronic Obstructive Pulmonary Disease Market Size (M USD) (2019-2030)
Figure 6. Global Chronic Obstructive Pulmonary Disease Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Chronic Obstructive Pulmonary Disease Market Size by Country (M USD)
Figure 11. Chronic Obstructive Pulmonary Disease Sales Share by Manufacturers in 2023
Figure 12. Global Chronic Obstructive Pulmonary Disease Revenue Share by Manufacturers in 2023
Figure 13. Chronic Obstructive Pulmonary Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Chronic Obstructive Pulmonary Disease Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Chronic Obstructive Pulmonary Disease Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Chronic Obstructive Pulmonary Disease Market Share by Type
Figure 18. Sales Market Share of Chronic Obstructive Pulmonary Disease by Type (2019-2024)
Figure 19. Sales Market Share of Chronic Obstructive Pulmonary Disease by Type in 2023
Figure 20. Market Size Share of Chronic Obstructive Pulmonary Disease by Type (2019-2024)
Figure 21. Market Size Market Share of Chronic Obstructive Pulmonary Disease by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Chronic Obstructive Pulmonary Disease Market Share by Application
Figure 24. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Application (2019-2024)
Figure 25. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Application in 2023
Figure 26. Global Chronic Obstructive Pulmonary Disease Market Share by Application (2019-2024)
Figure 27. Global Chronic Obstructive Pulmonary Disease Market Share by Application in 2023
Figure 28. Global Chronic Obstructive Pulmonary Disease Sales Growth Rate by Application (2019-2024)
Figure 29. Global Chronic Obstructive Pulmonary Disease Sales Market Share by Region (2019-2024)
Figure 30. North America Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Chronic Obstructive Pulmonary Disease Sales Market Share by Country in 2023
Figure 32. U.S. Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Chronic Obstructive Pulmonary Disease Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Chronic Obstructive Pulmonary Disease Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Chronic Obstructive Pulmonary Disease Sales Market Share by Country in 2023
Figure 37. Germany Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Chronic Obstructive Pulmonary Disease Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Chronic Obstructive Pulmonary Disease Sales Market Share by Region in 2023
Figure 44. China Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Chronic Obstructive Pulmonary Disease Sales and Growth Rate (K Units)
Figure 50. South America Chronic Obstructive Pulmonary Disease Sales Market Share by Country in 2023
Figure 51. Brazil Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Chronic Obstructive Pulmonary Disease Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Chronic Obstructive Pulmonary Disease Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Chronic Obstructive Pulmonary Disease Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Chronic Obstructive Pulmonary Disease Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Chronic Obstructive Pulmonary Disease Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Chronic Obstructive Pulmonary Disease Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Chronic Obstructive Pulmonary Disease Market Share Forecast by Type (2025-2030)
Figure 65. Global Chronic Obstructive Pulmonary Disease Sales Forecast by Application (2025-2030)
Figure 66. Global Chronic Obstructive Pulmonary Disease Market Share Forecast by Application (2025-2030)
